Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 1
2015 2
2018 1
2019 1
2020 3
2021 4
2022 1
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study.
Dorward J, Sookrajh Y, Khubone T, van der Molen J, Govender R, Phakathi S, Lewis L, Bottomley C, Maraj M, Lessells RJ, Naidoo K, Butler CC, Van Heerden R, Garrett N. Dorward J, et al. Among authors: sookrajh y. Lancet HIV. 2023 May;10(5):e284-e294. doi: 10.1016/S2352-3018(23)00047-4. Epub 2023 Mar 28. Lancet HIV. 2023. PMID: 37001536 Free PMC article.
Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa.
Asare K, Lewis L, van der Molen J, Sookrajh Y, Khubone T, Moodley P, Lessells RJ, Naidoo K, Sosibo P, Garrett N, Dorward J. Asare K, et al. Among authors: sookrajh y. Open Forum Infect Dis. 2023 Nov 16;10(12):ofad583. doi: 10.1093/ofid/ofad583. eCollection 2023 Dec. Open Forum Infect Dis. 2023. PMID: 38045558 Free PMC article.
Diagnostic Accuracy of the Rapid Xpert HIV-1 Viral Load XC, Xpert HIV-1 Viral Load, & m-PIMA HIV-1/2 Viral Load in South African Clinics.
Dorward J, Naidoo J, Moodley P, Sookrajh Y, Samsunder N, Sayed F, Naicker N, Fanshawe T, Drain PK, Lessells RJ, Hayward G, Butler CC, Garrett N. Dorward J, et al. Among authors: sookrajh y. J Acquir Immune Defic Syndr. 2022 Oct 1;91(2):189-196. doi: 10.1097/QAI.0000000000003037. Epub 2022 Jun 13. J Acquir Immune Defic Syndr. 2022. PMID: 36094486 Free PMC article.
Point-of-Care Viral Load Testing to Manage HIV Viremia During the Rollout of Dolutegravir-Based ART in South Africa: A Randomized Feasibility Study (POwER).
Dorward J, Sookrajh Y, Lessells R, Bulo E, Naidoo J, Naidoo K, Bodley N, Khanyile M, Van Vuuren CJ, Moodley P, Samsunder N, Lewis L, Drain PK, Hayward G, Butler CC, Garrett N. Dorward J, et al. Among authors: sookrajh y. J Acquir Immune Defic Syndr. 2023 Aug 15;93(5):403-412. doi: 10.1097/QAI.0000000000003212. J Acquir Immune Defic Syndr. 2023. PMID: 37120720 Free PMC article. Clinical Trial.
Clinical outcomes after extended 12-month antiretroviral therapy prescriptions in a community-based differentiated HIV service delivery programme in South Africa: a retrospective cohort study.
Lewis L, Sookrajh Y, van der Molen J, Khubone T, Sosibo P, Maraj M, van Heerden R, Little F, Kassanjee R, Garrett N, Dorward J. Lewis L, et al. Among authors: sookrajh y. J Int AIDS Soc. 2023 Sep;26(9):e26164. doi: 10.1002/jia2.26164. J Int AIDS Soc. 2023. PMID: 37767825 Free PMC article.
Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy.
Dorward J, Lessells R, Govender K, Moodley P, Samsunder N, Sookrajh Y, Turner P, Butler CC, Hayward G, Gandhi M, Drain PK, Garrett N. Dorward J, et al. Among authors: sookrajh y. J Int AIDS Soc. 2023 Sep;26(9):e26172. doi: 10.1002/jia2.26172. J Int AIDS Soc. 2023. PMID: 37735860 Free PMC article.
Clinical outcomes after the introduction of dolutegravir for second-line antiretroviral therapy in South Africa: a retrospective cohort study.
Asare K, Sookrajh Y, van der Molen J, Khubone T, Lewis L, Lessells RJ, Naidoo K, Sosibo P, van Heerden R, Garrett N, Dorward J. Asare K, et al. Among authors: sookrajh y. medRxiv [Preprint]. 2023 Jul 8:2023.07.07.23292347. doi: 10.1101/2023.07.07.23292347. medRxiv. 2023. PMID: 37461582 Free PMC article. Preprint.
Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy.
Dorward J, Sookrajh Y, Lessells R, Bulo E, Bodley N, Singh L, Moodley P, Samsunder N, Drain PK, Hayward G, Butler CC, Garrett N. Dorward J, et al. Among authors: sookrajh y. J Acquir Immune Defic Syndr. 2024 Apr 15;95(5):e8-e11. doi: 10.1097/QAI.0000000000003385. Epub 2024 Mar 11. J Acquir Immune Defic Syndr. 2024. PMID: 38489494 Free PMC article.
23 results